Evidence map›Paper›PMID 39366523›Full record

ArticleThe Journal of allergy and clinical immunology2025

Role of anti-IgE in immediate drug allergy.

Lily Li, Kimberly G Blumenthal

Abstract readEditorial
In one paragraph

Article in The Journal of allergy and clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lily LiDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Wash. Electronic address: lli99@uw.edu.
Kimberly G BlumenthalDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.

Funding

Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)U01AI184071 · NIAID · MAYO CLINIC JACKSONVILLE · PI Kimberly G. Blumenthal, DAVID A KHAN · 2024 to 2026
$9.4M
Clinical Impact and Epidemiology of Nonsteroidal Anti-inflammatory Drug AllergiesK23AI163371 · NIAID · UNIVERSITY OF WASHINGTON · PI LI, LILY · 2021 to 2025
$921k
AHRQ HHS R01 HS029319NIAID NIH HHS K23 AI163371NIAID NIH HHS U01 AI184071
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug allergyhypersensitivityIgEomalizumab

Identifiers

PMID39366523
PMCPMC11881703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.